Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-24

Clinical Trial Update: Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of testosterone replacement therapy on endothelial dysfunction, inflammation and insulin resistance in hypogonadot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: Gulhane School of Medicine | Conditions: Hypogonadotrophic Hypogonadism | Phase 4 | Status: COMPLETED